Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.

Literature DB >> 17507997

The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.

N Pemmaraju, A R Moliterno, D M Williams, O Rogers, J L Spivak.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2007 PMID： 17507997 DOI： 10.1038/sj.leu.2404755

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

Authors: Eric Lippert; François Girodon; Emma Hammond; Jaroslav Jelinek; N Scott Reading; Boris Fehse; Katy Hanlon; Mirjam Hermans; Céline Richard; Sabina Swierczek; Valérie Ugo; Serge Carillo; Véronique Harrivel; Christophe Marzac; Daniela Pietra; Marta Sobas; Morgane Mounier; Marina Migeon; Sian Ellard; Nicolaus Kröger; Richard Herrmann; Josef T Prchal; Radek C Skoda; Sylvie Hermouet
Journal: Haematologica Date: 2008-11-10 Impact factor: 9.941

2. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

Authors: Karen K Ballen; Ann E Woolfrey; Xiaochun Zhu; Kwang Woo Ahn; Baldeep Wirk; Mukta Arora; Biju George; Bipin N Savani; Brian Bolwell; David L Porter; Ed Copelan; Gregory Hale; Harry C Schouten; Ian Lewis; Jean Yves Cahn; Joerg Halter; Jorge Cortes; Matt E Kalaycio; Joseph Antin; Mahmoud D Aljurf; Matthew H Carabasi; Mehdi Hamadani; Philip McCarthy; Steven Pavletic; Vikas Gupta; H Joachim Deeg; Richard T Maziarz; Mary M Horowitz; Wael Saber
Journal: Biol Blood Marrow Transplant Date: 2012-03-24 Impact factor: 5.742

3. The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.

Authors: Youwen Qin; Xiaorui Wang; Chuxian Zhao; Chun Wang; Yining Yang
Journal: Int J Hematol Date: 2015-05-22 Impact factor: 2.490

Review 4. Polycythemia Vera.

Authors: Jerry L Spivak
Journal: Curr Treat Options Oncol Date: 2018-03-07

The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.

1. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

2. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

3. The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.

Review 4. Polycythemia Vera.

5. Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.

Review 6. Platelet Heterogeneity in Myeloproliferative Neoplasms.

7. Comparison of clinicopathologic findings according to JAK2 V617F mutation in patients with essential thrombocythemia.

8. Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.

9. Abdominal venous thrombosis presenting in myeloproliferative neoplasm with JAK2 V617F mutation: a case report.

10. The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms.